Are Analysts Bullish CareTech Holdings plc (LON:CTH) After Last Week?

Out of 2 analysts covering CareTech Holdings PLC (LON:CTH), 3 rate it “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. CareTech Holdings PLC was the topic in 14 analyst reports since July 29, 2015 according to StockzIntelligence Inc. Below is a list of CareTech Holdings plc (LON:CTH) latest ratings and price target changes.

01/03/2016 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 307.00 New Target: GBX 307.00 Maintain
01/03/2016 Broker: Panmure Gordon Rating: Buy Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
22/02/2016 Broker: Panmure Gordon Rating: Buy Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
19/02/2016 Broker: Panmure Gordon Rating: Buy New Target: GBX 235.00 Maintain
19/02/2016 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 307.00 New Target: GBX 307.00 Maintain
15/12/2015 Broker: Panmure Gordon Rating: Buy Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
08/12/2015 Broker: Panmure Gordon Rating: Buy Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
08/12/2015 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 307.00 New Target: GBX 307.00 Maintain
01/12/2015 Broker: Panmure Gordon Rating: Buy Old Target: GBX 360.00 New Target: GBX 360.00 Maintain
01/12/2015 Broker: Canaccord Genuity Rating: Buy Old Target: GBX 307.00 New Target: GBX 307.00 Maintain

The stock decreased 0.85% or GBX 2 on March 8, hitting GBX 233. About 23,538 shares traded hands. CareTech Holdings plc (LON:CTH) has declined 7.98% since August 10, 2015 and is downtrending. It has underperformed by 3.12% the S&P500.

CareTech Holdings PLC is a United Kingdom firm providing social care. The company has a market cap of 146.20 million GBP. The Firm offers outsourcing provision for social care commissioners. It has 17.06 P/E ratio. It provides care and support for people with learning disabilities, mental illness, autistic spectrum disorder and physical impairments.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

Add Comment